Affimed Therapeutics (AFMD) PT Lowered to $11 at Stifel
Stifel analyst Bradley Canino lowered the price target on Affimed Therapeutics (NASDAQ: AFMD) to $11.00 (from $12.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)